Filing Details

Accession Number:
0001144204-18-014217
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-12 21:11:22
Reporting Period:
2018-03-08
Accepted Time:
2018-03-12 21:11:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1069899 Phibro Animal Health Corp PAHC Pharmaceutical Preparations (2834) 131840497
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1601576 M Daniel Bendheim 300 Frank W. Burr Boulevard
Suite 21
Teaneck NJ 07666
Exec. Vp, Corporate Strategy Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2018-03-08 3,425 $11.83 3,425 No 4 M Direct
Class A Common Stock Disposition 2018-03-08 3,425 $40.00 0 No 4 S Direct
Class A Common Stock Acquisiton 2018-03-09 6,576 $11.83 6,576 No 4 M Direct
Class A Common Stock Disposition 2018-03-09 6,576 $40.03 0 No 4 S Direct
Class A Common Stock Acquisiton 2018-03-12 13,162 $11.83 13,162 No 4 M Direct
Class A Common Stock Disposition 2018-03-12 13,162 $40.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Option to purchase Common Stock Disposition 2018-03-08 3,425 $0.00 3,425 $11.83
Class A Common Stock Option to purchase Common Stock Disposition 2018-03-09 6,576 $0.00 6,576 $11.83
Class A Common Stock Option to purchase Common Stock Disposition 2018-03-12 13,162 $0.00 13,162 $11.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,738 2012-03-01 2019-02-28 No 4 M Direct
13,162 2012-03-01 2019-02-28 No 4 M Direct
0 2012-03-01 2019-02-28 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.10, inclusive.